Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.

Maurizio Averna, Luc Missault, Margus Viigimaa, Philippe Brudi, Viigimaa, Viigimaa, Amy O. Johnson-Levonas, Vandormael, Helena Vaverkova, Michel Farnier, Maurizio R. Averna, Massaad

Risultato della ricerca: Articlepeer review

60 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.'. Insieme formano una fingerprint unica.

Medicine & Life Sciences